Clinical trial
Cyclosporine Implant for Ocular Graft-Versus-Host Disease
NCT00102583 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00102583 |
|---|---|
| Title | Cyclosporine Implant for Ocular Graft-Versus-Host Disease |
| Official title | A Phase I Clinical Trial to Study the Safety of a Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease (GVHD1) |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Graft Vs Host Disease |
| Intervention type | Drug |
| Interventions | Subconjunctival Cyclosporine Implant |
| Enrollment | 4 |
| Start date | Oct 14, 2004 |
| Primary completion | Mar 15, 2011 |
| Completion | Mar 15, 2011 |
| First posted | Jan 31, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: